Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.631, 2011-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Intervention proves worth it for lowering inappropriate meds
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. :
Access to resources
Recommend
Budesonide/formoterol proves its worth in COPD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 439, 2003-01 ,pp. :
Gemcitabine proves its worth in the fight against cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. :
Capecitabine proves its worth in colorectal, breast cancer
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :
Eprosartan proves its worth for hypertension in elderly
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. :